Abbott is facing a warning letter from FDA regarding its Freestyle Libre family of continuous glucose monitoring (CGM) devices for use in diabetes management. The agency said it received responses ...
"With the Libre device people are scanning on their own an average of 16 times per day, which is quite remarkable and a testament of how easy the technology is to use." But even more interesting for ...
Abbott has received CE Mark clearance for the second generation of its Freestyle Libre device, which will allow the company to make the device available to users in Europe. It will be rolled out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results